Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06237829 · ClinicalTrials.gov registry record · NA
Testing Tactile Aids With Blind Subjects
A NA study of Blindness and Vision, Low, sponsored by University of Delaware.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06237829: Recruiting NA study of Blindness and Vision, Low, sponsored by University of Delaware.
NCT06237829 is a NA study of Blindness and Vision, Low that is actively recruiting participants, run by University of Delaware. The registered enrollment target is 100 participants, above the 45-participant average among 7 other Blindness trials with a reported enrollment target (122% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06237829, a NA study of Blindness and Vision, Low, is actively recruiting participants, sponsored by University of Delaware.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this project is to create richer tactile aids by using materials chemistry to create tactile sensations in tactile aids, as an alternative to traditional physical bumps, lines, or textures. These materials are commonly used in household products, but have not yet been used to enrich tactile aids. Successful outcomes are primarily the accuracy with which low vision or blind subjects identify objects made from tactile coatings versus traditional tactile aids. Other outcomes include time to completion of the task, or the number of distinctive categories that participants can identify.
Primary Outcome
Researchers will create a tactile plot of the GDP of four countries on an xy plot. The different countries are denoted from a combination of traditional lines or bump-dashed lines, and from a line made with a tactile coating. At three positions along the x-axis of on the plot, the relative GDP of which country has the most will change. Participants will be asked to give which country is the highest GDP and the lowest at these three positions. The primary outcome measure is if when asked, what is
Conditions Studied
Interventions
- BEHAVIORAL Single bump acuity
- BEHAVIORAL Optimal spacing between bumps
- BEHAVIORAL Improving signal from a single bump with designer materials
Study Locations (1)
Delaware
- University of Delaware - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT06237829 shows while recruiting
NCT06237829 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 45-participant average among 7 other Blindness trials with a reported enrollment target (122% higher).
The record links to 2 conditions, with Blindness appearing as the primary indexed condition, and to 3 interventions - of which Single bump acuity is the first listed.
NCT06237829 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT06237829 about?
NCT06237829 is a clinical study titled "Testing Tactile Aids With Blind Subjects". The objective of this project is to create richer tactile aids by using materials chemistry to create tactile sensations in tactile aids, as an alternative to traditional physical bumps, lines, or textures. These materials are commonly used in household products, but have not yet been used to enrich...
What is the current status of trial NCT06237829?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2021-09-01. Estimated completion is 2027-12.
What conditions does trial NCT06237829 study?
This clinical trial studies the following conditions: Blindness, Vision, Low.
What interventions are being tested in trial NCT06237829?
The interventions under investigation include: Single bump acuity (BEHAVIORAL), Optimal spacing between bumps (BEHAVIORAL), Improving signal from a single bump with designer materials (BEHAVIORAL).
Who is sponsoring clinical trial NCT06237829?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06237829 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blindness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind
COMPLETED · NA
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
ACTIVE NOT RECRUITING · Phase 2
-
Enhanced Tactile Memory in the Blind
COMPLETED
-
Brain Plasticity of Verbal Memory in the Blind
COMPLETED
-
Natural History Study of CEP290-Related Retinal Degeneration
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI